-
Business
U.S. Stocks Slide as UnitedHealth Probe and Economic Woes Weigh on Markets
Wall Street Sees Red Amid UnitedHealth Investigation and Weak Economic Data U.S. stocks tumbled on Friday, with all three major…
Read More » -
Business
UnitedHealth Group (NYSE:UNH) Shares Plunge 7% Amid DOJ Fraud Investigation
DOJ Launches Civil Fraud Probe into UnitedHealth’s Medicare Advantage Practices Shares of UnitedHealth Group (NYSE:UNH) tumbled approximately 7% in premarket…
Read More » -
Business
Wall Street Struggles for Direction Amid Walmart’s Outlook and UnitedHealth Investigation
Markets Mixed as Wall Street Recovers from Thursday’s Sell-Off Wall Street’s major indexes showed a mixed performance on Friday as…
Read More » -
Business
FDA Declares End to Semaglutide Shortage, Grants Grace Period for Compounders
FDA Ends GLP-1 Shortage, Pauses Enforcement Against Compounders The U.S. Food and Drug Administration (FDA) announced Friday that it will…
Read More » -
Business
Hims & Hers Acquires Peptide Facility Amid Weight Loss Drug Shift, Stock Drops 20%
Hims & Hers Health (NYSE: HIMS) has acquired a California-based peptide facility to strengthen its supply chain and expand its…
Read More » -
Business
FDA Declares End to Ozempic and Wegovy Shortages, Impacting Hims & Hers Health (NYSE:HIMS)
Novo Nordisk’s Ozempic and Wegovy No Longer in Short Supply, Creating Challenges for Hims & Hers The U.S. Food and…
Read More » -
Business
Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings and Dividend Announcement
Arbor Realty Trust (NYSE:ABR) reported Q4 2024 earnings with lower-than-expected results, as EPS and revenue both came in below analyst…
Read More » -
Business
Goldman Sachs Reveals Stocks with Biggest Short Interest Shifts Since U.S. Election
Goldman Sachs analysts have identified the stocks with the largest increases and decreases in short interest since the U.S. election…
Read More » -
Business
Bluebird Bio (NASDAQ:BLUE) to Go Private in $3 Billion M&A Deal with Carlyle and SK Capital
Bluebird Bio Stock Crashes 37% as Carlyle and SK Capital Plan Takeover Shares of bluebird bio (NASDAQ:BLUE) plummeted ~37% in…
Read More » -
Business
Apple (NASDAQ:AAPL) Removes Advanced Data Protection in the UK Amid Government Pressure
Apple (NASDAQ:AAPL) is withdrawing its Advanced Data Protection (ADP) feature for cloud data in the United Kingdom after facing government…
Read More » -
Business
Coinbase (NASDAQ:COIN) Surges as SEC Agrees to Dismiss Lawsuit with No Fines
Coinbase CEO Brian Armstrong Announces Victory in SEC Legal Battle Shares of Coinbase (NASDAQ:COIN) climbed 2.4% in early Friday trading…
Read More » -
Business
Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) Declares $0.1700 Dividend for February 2024
PFFA Maintains Consistent Dividend Payout for Investors Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) has announced a monthly dividend of…
Read More » -
Business
Kenvue (NYSE:KVUE) Rises on Takeover Speculation Amid Activist Pressure
Kenvue Gains Amid Rumors of Acquisition Interest Shares of Kenvue (NYSE:KVUE), the consumer health company known for brands like Tylenol,…
Read More » -
Business
Arbor Realty Trust (NYSE:ABR) Posts Mixed Q4 Results as Earnings Miss but NII Beats Estimates
Arbor Realty Trust Reports Q4 2024 Financial Results Arbor Realty Trust (NYSE:ABR) delivered a mixed performance in its Q4 2024…
Read More » -
Business
J.P. Morgan Upgrades Grab Holdings (GRAB) to Overweight, Sees Strong Earnings Growth Ahead
Grab Holdings (NASDAQ: GRAB) received a major boost from J.P. Morgan, which upgraded the stock to Overweight from Neutral, citing…
Read More » -
Business
Goldman Sachs Identifies Key Hedge Fund Shifts Following Post-Election Policies
Hedge Funds Reposition Portfolios Amidst Regulatory and Trade Policy Changes Goldman Sachs strategists have observed significant shifts in hedge fund…
Read More » -
Business
Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings: EPS and Revenue Fall Short of Expectations
Arbor Realty Trust (NYSE:ABR) reported Q4 2024 earnings with lower-than-expected results, as EPS and revenue both came in below analyst…
Read More » -
Business
Gilead Seladelpar Wins EU Approval for Rare Liver Disease Treatment
Gilead Sciences (NASDAQ: GILD) has secured conditional marketing authorization from the European Commission (EC) for seladelpar, a breakthrough treatment for…
Read More » -
Business
Stock Market Movers: MercadoLibre and Celsius Surge, UnitedHealth and Akamai Drop
Stock Futures Slip as Investors Eye Economic Data; Here’s What’s Moving Markets Stock futures edged lower on Friday as investors…
Read More » -
Business
Five9 (NASDAQ:FIVN) Surges on Strong Q4 Results and AI Growth Acceleration
Five9 (NASDAQ:FIVN) shares soared in early market trading on Friday after the company’s Q4 2024 financial results exceeded expectations, showcasing…
Read More »